Health Condition 1: I504- Combined systolic (congestive) anddiastolic (congestive) heart failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Anemic patients as per WHO criteria(Hemoglobin 2) Patients with total iron binding capacity value above 350mcg/dl 3) Patients with heart failure who have LVEF 40-50% in both the groups 4) Patients willing to participate in the study
Exclusion criteria
Exclusion criteria: 1) Patient 2) Patients who already on Iron and Erythropoietin therapy 3) Patients who are allergic to Iron/Erythropoietin 4) Patients history of Anaphylaxis treatment 5) Patients who are in add on therapy or cardiac condition deteriorates during the study will be excluded 6) Patients with hemolytic anemia are excluded 7) Pregnant women 8) Patients who are not willing to give informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patients show positive outcome with parenteral iron therapy will improve the cardiac function of heart failure patients with iron deficiency anemia after anemiaTimepoint: Baseline, 1, 2 and 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of patients health-related quality of life (HRQoL) in Heart Failure with iron deficiency after anemia correctionTimepoint: Baseline, 1, 2 and 3 months | — |
Countries
India
Contacts
SRM Institute of Science and Technology